BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
116 hedge funds and large institutions have $294M invested in BioSpecifics Technologies Corp. in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 13 closing their positions.
31% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 13
22% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 37
12% more capital invested
Capital invested by funds: $262M → $294M (+$32.7M)
3% more funds holding
Funds holding: 113 → 116 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
+$2.89M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$2.72M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.69M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.43M |
| 5 |
WG
Winton Group
London,
United Kingdom
|
+$1.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$5.88M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$1.26M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.2M |
| 4 |
Millennium Management
New York
|
-$755K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$541K |
BSTC Hedge Fund Activity: Q2 2020 in Review
116 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2020, worth a combined $294M — up 12% from $262M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new BSTC positions and 13 closed out — a net gain of 4 holders — while 45 added to existing stakes and 37 trimmed.
The largest buyer was Punch & Associates Investment Management, opening a new position worth an estimated $2.89M. The largest seller was Goldman Sachs, cutting an estimated $5.88M.
- 116 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2020, up from 113 in Q1 2020.
- Funds reported $294M of BioSpecifics Technologies Corp. stock for Q2 2020, up 12% quarter-over-quarter.
- 17 funds opened new BioSpecifics Technologies Corp. positions in Q2 2020 and 13 closed out, a net change of +4 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q2 2020 was Punch & Associates Investment Management, an estimated $2.89M added.
- The largest BioSpecifics Technologies Corp. seller in Q2 2020 was Goldman Sachs, an estimated $5.88M sold.
Based on aggregated 13F filings for Q2 2020.